ヘルスケアコールドチェーンロジスティクスの世界市場レポート＆予測、2024年～2032年

ヘルスケアコールドチェーンロジスティクスの世界市場規模は、2023年に176億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて2.9%の成長率（CAGR）を示し、2032年には230億米ドルに達すると予測しています。ワクチンや生物製剤の需要増加、温度変化に敏感なヘルスケア製品に対する厳しい規制要件や品質基準の導入、製薬業界の急成長などが、市場を後押しする主な要因となっています。

ヘルスケアコールドチェーンロジスティクスとは、温度に敏感な医薬品、ワクチン、生物製剤を管理された温度範囲内で取り扱い、輸送、保管する専門的なプロセスを指します。製造から流通、最終的にはエンドユーザーまでのサプライチェーンを通じて、これらの医療製品の有効性と安全性を維持することが不可欠です。コールドチェーン・ロジスティクスでは、冷蔵または断熱コンテナ、温度管理された倉庫、および高度な監視技術を使用して、製品が指定された温度範囲内に保たれるようにし、品質や有効性を損なう可能性のある温度逸脱から製品を保護します。その結果、この重要なシステムは、公衆衛生を守り、世界中で信頼できるヘルスケア製品の供給を確保する上で重要な役割を果たしています。

製品の完全性と有効性を維持するために信頼性が高く効率的なコールドチェーンロジスティクスシステムを必要とする、温度に敏感な医薬品、ワクチン、生物製剤に対する需要の高まりは、予測期間中の市場の成長を刺激するでしょう。さらに、製薬・バイオテクノロジー産業の急速な拡大により、温度制御された特殊な輸送・保管ソリューションに対するニーズが高まっていることも、市場成長にプラスの影響を与えています。これとは別に、最近のコロナウイルス（COVID-19）パンデミックの発生時など、世界の健康上の緊急事態やワクチン接種プログラムの増加は、救命医療製品のタイムリーで安全な流通を確保するためのシームレスなヘルスケアコールドチェーンロジスティクスの需要を増大させています。さらに、適正流通規範（GDP）ガイドラインなど、ヘルスケア製品に関するいくつかの厳しい規制要件や品質基準が、厳格な取り扱い・監視プロトコルを遵守するための専門的なコールドチェーンロジスティクスサービスの採用を加速させています。さらに、個別化医療や温度に敏感なことが多いバイオ医薬品への注目が高まっていることも、市場の成長に寄与しています。

ヘルスケアコールドチェーン物流市場の動向と促進要因：

温度に敏感な医療製品への需要の高まり

ヘルスケアコールドチェーンロジスティクス市場は、温度感受性の高い医薬品、ワクチン、生物製剤に対する世界の需要の増加によって活性化しています。製薬・バイオテクノロジー産業が拡大・革新を続ける中、輸送・保管中のデリケートな医療製品の完全性と有効性を確保するため、信頼性が高く効率的なコールドチェーンシステムに対するニーズが高まっています。製品の品質と有効性を損なう可能性のある温度上昇を防ぐには、サプライチェーン全体を通して制御された温度範囲を維持することが極めて重要です。このため、需要の高まりに対応し、温度に敏感なヘルスケア製品の安全で信頼性の高い流通を確保するため、ヘルスケアに特化したコールドチェーンロジスティクスサービスやテクノロジーへの投資が増加しています。

世界の保健衛生上の緊急事態と予防接種プログラムの増加

パンデミックや疾病アウトブレイクなど、世界の健康危機の蔓延は、ヘルスケアコールドチェーンロジスティクスの需要を高めています。このような危機に際しては、ワクチン、医薬品、医療用品をタイムリーかつ効率的に流通させることが、疾病の蔓延を抑え、公衆衛生を守る上で極めて重要になります。効果的なワクチン接種プログラムは、製造から投与までワクチンの効力と有効性を確実に維持する、堅牢なヘルスケアコールドチェーンロジスティクス・システムに依存しています。保健衛生上の緊急事態への対応や大規模なワクチン接種キャンペーンの実施が急務となっていることから、ヘルスケア分野におけるシームレスなコールドチェーン・ロジスティクスの重要性が浮き彫りになり、それが世界の保健衛生の成果に与える影響が浮き彫りになっています。

厳格な規制遵守と品質基準の実施

ヘルスケア産業は、患者の安全性と製品の有効性を確保するため、厳しい規制要件と品質基準の下で運営されています。温度に敏感な医療製品については、これらの製品が指定された温度範囲内で保管、輸送、取り扱われることを保証するために、適正流通規範（GDP）ガイドラインの遵守が不可欠です。これらの規制へのコンプライアンスを維持するためには、ヘルスケアのコールドチェーンロジスティクスプロセスにおいて高い精度と説明責任が求められます。法規制への準拠が重視されるようになったことで、サプライチェーン全体を通じて品質と適合性を確保するための強固なモニタリング、データ管理、検証機能を提供する高度なヘルスケアコールドチェーンロジスティクス・ソリューションに対する需要が高まっています。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査目的
• 利害関係者
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 ヘルスケア用コールドチェーン製品の世界市場

• 過去、現在、将来の市場動向
• 市場セグメンテーション
  • バイオ医薬品
    • 歴史的、現在および将来の市場動向
    • バイオ医薬品に対するコールドチェーン要件
    • バイオ医薬品のコールドチェーン機会
  • ワクチン
    • 歴史的、現在および将来の市場動向
    • ワクチンのコールドチェーン要件
    • ワクチンのコールドチェーン機会
  • 臨床試験材料
    • 歴史的、現在および将来の市場動向
    • 治験薬のコールドチェーン要件
    • 臨床試験材料のコールドチェーン機会

第5章 ヘルスケアコールドチェーンロジスティクスサービス市場

• 現在および過去の市場動向
• COVID-19の影響
• 市場内訳：製品別
  • 治験材料
  • ワクチン
  • バイオ医薬品
• 市場内訳：セグメント別
  • 輸送
    • 現在の市場動向と過去の市場動向
    • 市場内訳：輸送タイプ別
    • 市場予測
  • 包装
    • 現在と過去の市場動向
    • 市場内訳：包装タイプ別
    • 市場予測
  • 計測機器
    • 現在の市場動向と過去の市場動向
    • 市場内訳：計測器タイプ別
    • 市場予測
• 市場：地域別
  • 北米
  • 欧州
  • アジア太平洋
  • 世界のその他の地域

第6章 バリューチェーン分析

• 医薬品製造施設
• 冷蔵倉庫
• 輸送（航空／海上／道路／鉄道）
• 流通センター
• 輸送（道路）
• エンドユーザー

第7章 価格分析

• 価格指標
• 価格構造
• コールドチェーン物流サービスと非コールドチェーン物流サービスのコスト比較

第8章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第9章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第10章 ヘルスケアコールドチェーンロジスティクス：どのように運営されているか？

• コールドチェーンの包装と輸送方法
  • ドライアイス
  • 液体窒素
  • ジェルパック
• コールドチェーンの設定
  • 初期検討事項
  • 適切なモデルの選択
  • 規制/カスタムクリアランス
  • 最終段階
  • 品質保証

第11章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Amerisource Bergen Corporation（World Courier）
  • Deutsche Post DHL Group
  • FedEx Corporation Services, Inc.
  • United Parcel Service of America, Inc.
  • Kuehne+Nagel International AG, Cavalier Logistics, Inc.
  • DB Schenker
  • Life ConEx
  • American Airlines Cargo
  • Continental Group
  • Marken

List of Figures

• Figure 1: Global: Healthcare Cold Chain Products Market: Breakup by Segment (in %), 2018-2023
• Figure 2: Global: Healthcare Cold Chain Products Market Forecast: Breakup by Segment (in Million US$), 2024-2032
• Figure 3: Global: Biopharmaceutical Market (in Billion US$), 2018-2023
• Figure 4: Global: Biopharmaceutical Market Forecast (in Billion US$), 2024-2032
• Figure 5: Global: Biosimilar Sales and (in Billion US$), 2023 & 2032
• Figure 6: Global: Biopharmaceutical Contract Manufacturing Market (in Billion US$), 2018-2023
• Figure 7: Global: Biopharmaceutical Contract Manufacturing Market Forecast (in Billion US$), 2024-2032
• Figure 8: Global: Vaccine Market (in Billion US$), 2018-2023
• Figure 9: Global: Vaccine Market Forecast (in Billion US$), 2024-2032
• Figure 10: Global: Healthcare Cold Chain Logistic Services Market: Breakup by Region (in %), 2023
• Figure 11: Global: Vaccine Production Volume by Region (in %)
• Figure 12: Europe: Vaccine Export Volume by Region (in %)
• Figure 13: Global: Clinical Trials Market (in Billion US$), 2018-2023
• Figure 14: Global: Clinical Trials Market - Spending on Biopharmaceuticals & Small Molecule Drugs (in Billion US$), 2018-2023
• Figure 15: Time Taken for Biopharmaceuticals to Get Approved (in Months)
• Figure 16: Global: Clinical Trials Market Forecast (in Billion US$), 2024-2032
• Figure 17: Global: Clinical Trials Market Forecast: Spending on Biopharmaceuticals & Small Molecule Drugs (in Billion US$) 2024-2032
• Figure 18: Global: Breakup of Biopharmaceuticals and Small Molecule Drugs in Preclinical & Clinical trials, (in %) 2023
• Figure 19: Top Reasons for Conducting Clinical Trials in Each Country (in %)
• Figure 20: Global: Healthcare Cold & Non-Cold Chain Products Market (in Billion US$), 2018-2023
• Figure 21: Global: Healthcare Cold & Non-Cold Chain Products Market Forecast (in Billion US$), 2024-2032
• Figure 22: Global: Potency of the Tetanus Component of a DTP Vaccine Stored for 45 Days at Various Temperatures
• Figure 23: Global: Contract Research & Manufacturing Market (in Billion US$), 2018-2023
• Figure 24: Global: Contract Research & Manufacturing Market Forecast (in Billion US$), 2024-2032
• Figure 25: Estimated Costs incurred in Various Pharmaceutical Operations
• Figure 26: A Typical Drug Supply Chain from the Manufacturer to the End User
• Figure 27: Global: Healthcare Cold Chain Logistic Services Market: Value Trends (in Billion US$), 2018-2023
• Figure 28: Global: Healthcare Non-Cold Chain Logistic Services Market (in Billion US$), 2018-2023
• Figure 29: Global: Healthcare Logistic Services Market: Share of Cold-Chain and Non-Cold Chain Services (in %), 2023
• Figure 30: Global: Healthcare Cold Chain Logistic Services Market Forecast: Value Trends (in Billion US$), 2024-2032
• Figure 31: Global: Healthcare Non-Cold Chain Logistic Services Market Forecast (in Billion US$), 2024-2032
• Figure 32: Global: Healthcare Logistic Services Market Forecast: Share of Cold-Chain and Non-Cold Chain Services (in %), 2032
• Figure 33: Global: Healthcare Cold Chain Logistic Services Market by Product (in %), 2023 & 2032
• Figure 34: Global: Clinical Trial Materials Cold Chain Logistic Services Market (in Billion US$), 2018-2023
• Figure 35: Global: Clinical Trial Materials Cold Chain Logistic Services Market Forecast (in Billion US$), 2024-2032
• Figure 36: Global: Vaccines Cold Chain Logistic Services Market (in Billion US$), 2018-2023
• Figure 37: Global: Vaccines Cold Chain Logistic Services Market Forecast (in Billion US$), 2024-2032
• Figure 38: Global: Biopharmaceuticals Cold Chain Logistic Services Market (in Billion US$), 2018-2023
• Figure 39: Global: Biopharmaceuticals Cold Chain Logistic Services Market Forecast (in Billion US$), 2024-2032
• Figure 40: Global: Healthcare Cold Chain Logistic Services Market by Segment (in %), 2023 & 2032
• Figure 41: Global: Healthcare Cold Chain Transportation Services Market (in Billion US$), 2018-2023
• Figure 42: Global: Healthcare Cold Chain Transportation Services Market: Breakup by Transportation Mode (in %), 2023
• Figure 43: Global: Healthcare Cold Chain Transportation Services Market Forecast (in Billion US$), 2024-2032
• Figure 44: Global: Healthcare Cold Chain Packaging Services Market (in Billion US$), 2018-2023
• Figure 45: Global: Healthcare Cold Chain Packaging Services Market: Breakup by Packaging Type (in %), 2023
• Figure 46: Global: Healthcare Cold Chain Packaging Services Market Forecast (in Billion US$), 2024-2032
• Figure 47: Global: Healthcare Cold Chain Instrumentation Services Market (in Billion US$), 2018-2023
• Figure 48: Global: Healthcare Cold Chain Instrumentation Services Market: Breakup by Instrumentation Type (in %), 2023
• Figure 49: Global: Healthcare Cold Chain Instrumentation Services Market Forecast (in Billion US$), 2024-2032
• Figure 50: Global: Healthcare Cold Chain Logistic Spending by Region (in US$ Billion), 2020, 2023, 2024, 2026 and 2032
• Figure 51: North America: Healthcare Cold Chain Logistic Services Market (in Billion US$), 2018-2023
• Figure 52: North America: Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2024-2032
• Figure 53: Europe: Healthcare Cold Chain Logistic Services Market (in Billion US$), 2018-2023
• Figure 54: Europe: Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2024-2032
• Figure 55: Asia Pacific: Healthcare Cold Chain Logistic Services Market (in Billion US$), 2018-2023
• Figure 56: Asia Pacific: Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2024-2032
• Figure 57: Rest of the World: Healthcare Cold Chain Logistic Services Market (in Billion US$), 2018-2023
• Figure 58: Rest of the World: Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2024-2032
• Figure 59: Global: Healthcare Cold Chain Logistics Industry: SWOT Analysis
• Figure 60: Global: Healthcare Cold Chain Logistics Industry: Value Chain Analysis
• Figure 61: Global: Healthcare Cold Chain Logistics Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Healthcare Cold Chain Products Market: Breakup by Segment (in Billion US$), 2018-2023
• Table 2: Global: Healthcare Cold Chain Products Market Forecast: Breakup by Segment (in Billion US$), 2024-2032
• Table 3: Global: Biopharmaceutical Market: Sales by Class (in Billion US$), 2018-2023
• Table 4: Global: Biopharmaceutical Market Forecast: Sales by Class (in Billion US$), 2024-2032
• Table 5: Stability of Various Biopharmaceuticals at Room Temperature
• Table 6: Complexity of the Manufacturing Process Involved with Biopharmaceuticals and Small Molecule Drugs
• Table 7: Temperature Stability of Global: Biopharmaceutical Market Forecast- Sales by Class (in Billion US$), 2024-2032
• Table 8: The Effect of Temperature Excursions on the Usability of Vaccines
• Table 9: Ideal Storage Temperatures for Clinical Trial Materials
• Table 10: Various Regulations on Healthcare Cold Chain Logistic Requirements
• Table 11: Average Amount of Dry Ice for Packaging Frozen Goods in a Single Well Insulated Container
• Table 12: Dry Ice Containers
• Table 13: Refrigerated Shipping Containers with Gel Packs
• Table 14: Cold Chain Logistics: Comparison Matrix for Transport Modes

Abstract

The global healthcare cold chain logistics market size reached US$ 17.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 23.0 Billion by 2032, exhibiting a growth rate (CAGR) of 2.9% during 2024-2032. The increasing demand for vaccines and biologics, the implementation of stringent regulatory requirements and quality standards for temperature-sensitive healthcare products, and the rapid growth in the pharmaceutical industry are some of the major factors propelling the market.

Healthcare cold chain logistics refers to the specialized process of handling, transporting, and storing temperature-sensitive pharmaceuticals, vaccines, and biologics within a controlled temperature range. It is essential to maintain the efficacy and safety of these medical products throughout the supply chain, from manufacturing to distribution and ultimately to the end-user. Cold chain logistics involves the use of refrigerated or insulated containers, temperature-controlled warehouses, and advanced monitoring technologies to ensure that the products are kept within specified temperature ranges, protecting them from temperature excursions that could compromise their quality and effectiveness. As a result, this critical system plays a crucial role in safeguarding public health and ensuring the availability of reliable healthcare products across the globe.

The rising demand for temperature-sensitive pharmaceuticals, vaccines, and biologics that require a reliable and efficient cold chain logistics system to maintain product integrity and efficacy, will stimulate the growth of the market during the forecast period. Moreover, the escalating need for specialized temperature-controlled transportation and storage solutions due to the rapid expansion of the pharmaceutical and biotechnology industries is positively influencing the market growth. Apart from this, the increasing global health emergencies and vaccination programs, such as during the recent outbreak of the coronavirus (COVID-19) pandemic, has augmented the demand for seamless healthcare cold chain logistics to ensure the timely and safe distribution of life-saving medical products. Additionally, several stringent regulatory requirements and quality standards for healthcare products, including Good Distribution Practice (GDP) guidelines, has accelerated the adoption of specialized cold chain logistics services to comply with strict handling and monitoring protocols. Furthermore, the heightening focus on personalized medicine and biopharmaceuticals, which are often temperature-sensitive, is contributing to market growth.

Healthcare Cold Chain Logistics Market Trends/Drivers:

Growing demand for temperature-sensitive medical products

The market for healthcare cold chain logistics is fueled by an increase in the demand for temperature-sensitive pharmaceuticals, vaccines, and biologics worldwide. As the pharmaceutical and biotechnology industries continue to expand and innovate, there is a greater need for a reliable and efficient cold chain system to ensure the integrity and efficacy of these delicate medical products during transportation and storage. Maintaining a controlled temperature range throughout the supply chain is crucial to prevent temperature excursions that could compromise the quality and effectiveness of the products. This has led to a rise in investment in specialized healthcare cold chain logistics services and technologies to meet the growing demand and ensure the safe and reliable distribution of temperature-sensitive healthcare products.

Escalating global health emergencies and vaccination programs

The increasing prevalence of global health emergencies, such as pandemics and disease outbreaks, are contributing to the high demand for healthcare cold chain logistics. During these crises, the timely and efficient distribution of vaccines, pharmaceuticals, and medical supplies becomes crucial to curb the spread of diseases and protect public health. Effective vaccination programs rely on a robust healthcare cold chain logistics system to ensure that vaccines maintain their potency and efficacy from manufacturing to administration. The urgency to respond to health emergencies and implement large-scale vaccination campaigns highlights the critical importance of seamless cold chain logistics in the healthcare sector, underscoring its impact on global health outcomes.

Implementation of stringent regulatory compliance and quality standards

The healthcare industry operates under stringent regulatory requirements and quality standards to ensure patient safety and product efficacy. For temperature-sensitive medical products, adherence to Good Distribution Practice (GDP) guidelines is essential to guarantee that these products are stored, transported, and handled within the specified temperature ranges. Maintaining compliance with these regulations demands a high level of precision and accountability in healthcare cold chain logistics processes. The increase in emphasis on meeting regulatory compliance propels the demand for advanced healthcare cold chain logistics solutions that offer robust monitoring, data management, and validation capabilities to ensure quality and conformity throughout the supply chain.

Healthcare Cold Chain Logistics Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global healthcare cold chain logistics market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product and segment.

Breakup by Product:

Clinical Trial Materials

Vaccines

Biopharmaceuticals

Vaccines dominate the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes clinical trial materials, vaccines, and biopharmaceuticals. According to the report, vaccines represented the largest segment.

Vaccines play a central role as critical tools for preventing and controlling infectious diseases. They require stringent temperature control to maintain their potency and efficacy. The need for a robust cold chain is essential from the manufacturing stage to delivery to end-users, such as healthcare facilities and vaccination centers. Healthcare cold chain logistics ensures that vaccines are stored, transported, and handled within specified temperature ranges, safeguarding their integrity and effectiveness.

Moreover, the constant demand for vaccines, particularly during global health emergencies and vaccination programs, puts immense pressure on the healthcare cold chain logistics system to ensure timely and safe distribution. To meet this challenge, logistics providers are investing in specialized infrastructure, real-time monitoring technologies, and stringent quality control processes to maintain the cold chain's integrity and support the efficient delivery of vaccines, ultimately contributing to global health and disease prevention efforts, thus driving the growth of the vaccine segment.

Breakup by Segment:

Global Healthcare Cold Chain Logistics Market Share, By Segment (in %)

Transportation

Packaging

Instrumentation

20%

30%

50%

imarcgroup.com

Transportation 50

Packaging 30

Instrumentation 20

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Transportation

Packaging

Instrumentation

Packaging holds the largest share in the market

A detailed breakup and analysis of the market based on the segment has also been provided in the report. This includes transportation, packaging, and instrumentation. According to the report, packaging accounted for the largest market share.

The safe and effective transportation of temperature-sensitive medical products heavily relies on specialized packaging solutions that maintain product integrity throughout the supply chain. Packaging ensures that pharmaceuticals, vaccines, and biologics are insulated from temperature excursions, protecting them from degradation and maintaining their efficacy. Advanced thermal protection materials, insulated containers, and temperature-monitoring devices are incorporated into healthcare cold chain packaging to provide a controlled environment and real-time visibility during transportation and storage.

Packaging innovations enable longer shelf life, enhanced stability, and reduced risk of spoilage for temperature-sensitive healthcare products, facilitating their safe distribution to end users. As the demand for temperature-sensitive medical products continues to rise, the market for healthcare cold chain logistics invests in cutting-edge packaging technologies and solutions to ensure the safe and reliable delivery of medical products, contributing significantly to patient safety and public health.

Breakup by Region:

North America

Europe

Asia Pacific

Rest of the world

Asia Pacific exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, and Rest of the World. According to the report, Asia Pacific was the largest regional market for healthcare cold chain logistics.

Asia Pacific held the biggest share in the market since the region is witnessing substantial population growth and increasing levels of urbanization, leading to a rise in demand for temperature-sensitive medical products, such as vaccines and biologics, to cater to the healthcare needs of its vast population.

Additionally, the prevalence of infectious diseases and the occurrence of health emergencies necessitate efficient cold chain logistics to ensure timely and safe distribution of medical supplies and vaccines. The region's thriving pharmaceutical and biotechnology industries also fuels the demand for specialized healthcare cold chain services to maintain the integrity and efficacy of medical products during transportation and storage. The increasing investment in upgrading the healthcare infrastructure across the Asia Pacific region, continuous technological advancements by regional industry players, and stringent regulatory compliance further supports the expansion of the market, driving its importance in the region's healthcare ecosystem.

Competitive Landscape:

The market is experiencing steady growth as various key players operating in the healthcare cold chain logistics industry have made significant contributions by providing specialized and reliable solutions to address the unique challenges of transporting temperature-sensitive medical products. Manufacturers are heavily investing in advanced technologies and infrastructure to ensure seamless temperature control throughout the supply chain. They are also offering temperature-monitored storage facilities, refrigerated transportation, and real-time monitoring systems to maintain product integrity and compliance with strict regulatory requirements. Vendors also play a crucial role in implementing innovative packaging solutions and thermal protection materials to safeguard the products from temperature excursions during transit. Additionally, they contribute to the market growth by providing specialized training and expertise to ensure the proper handling and distribution of temperature-sensitive healthcare products, ultimately supporting the healthcare industry in delivering safe and effective medical treatments to patients across the globe. We also expect the market to witness a rise in strategic collaborations and partnerships amongst key players, continual product innovations, and technological advancements to drive healthy competition within the domain.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Amerisource Bergen Corporation (World Courier)

Deutsche Post DHL Group

FedEx Corporation Services, Inc.

United Parcel Service of America, Inc.

Kuehne + Nagel International AG

Cavalier Logistics, Inc.

DB Schenker

Life ConEx

American Airlines Cargo

Continental Group

Marken Ltd.

Recent Developments:

In December 2020, FedEx Corp, a leading logistics company, completed the acquisition of ShopRunner, a technology platform that connects retailers with online shoppers. This strategic move is expected to enhance the company's e-commerce capabilities significantly, empowering it to offer a more comprehensive and efficient logistics solution to its customers. With ShopRunner's expertise in online retail and customer engagement, FedEx can bolster its presence in the rapidly growing e-commerce market.

In December 2022, Kuehne+Nagel International AG, a renowned global logistics company, announced a significant milestone by entering into an agreement for the development of a state-of-the-art healthcare logistics focused airside facility in South Africa. This strategic move reflects the company's commitment to meeting the increasing demand for specialized cold chain logistics solutions in the healthcare sector. The new airside facility will be strategically located at an airport in South Africa, facilitating seamless and expedited transportation of temperature-sensitive medical products, including pharmaceuticals, vaccines, and biologics.

In February 2022, Cavalier Logistics UK, a prominent player in the logistics industry, has taken significant steps to bolster its presence across Europe. Through a strategic expansion initiative, the company has extended its footprint in various major European markets. This expansion comes as a testament to their commitment to improving their logistics capabilities and reach within the region. This move allows them to tap into new opportunities and serve a broader customer base while positioning themselves as a leading force in the European logistics landscape.

Key Questions Answered in This Report

• 1. What was the size of the global healthcare cold chain logistics market in 2023?
• 2. What is the expected growth rate of the global healthcare cold chain logistics market during 2024-2032?
• 3. What are the key factors driving the global healthcare cold chain logistics market?
• 4. What has been the impact of COVID-19 on the global healthcare cold chain logistics market?
• 5. What is the breakup of the global healthcare cold chain logistics market based on the product?
• 6. What is the breakup of the global healthcare cold chain logistics market based on the segment?
• 7. What are the key regions in the global healthcare cold chain logistics market?
• 8. Who are the key players/companies in the global healthcare cold chain logistics market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 The Global Healthcare Cold Chain Products Market

• 4.1 Historical, Current and Future Market Trends
• 4.2 Market Segments
  • 4.2.1 Biopharmaceuticals
    • 4.2.1.1 Historical, Current and Future Market Trends
    • 4.2.1.2 Cold Chain Requirements for Biopharmaceuticals
    • 4.2.1.3 Cold Chain Opportunities for Biopharmaceuticals
  • 4.2.2 Vaccines
    • 4.2.2.1 Historical, Current and Future Market Trends
    • 4.2.2.2 Cold Chain Requirements for Vaccines
    • 4.2.2.3 Cold Chain Opportunities for Vaccines
  • 4.2.3 Clinical Trial Materials
    • 4.2.3.1 Historical, Current and Future Market Trends
    • 4.2.3.2 Cold Chain Requirements for Clinical Trial Materials
    • 4.2.3.3 Cold Chain Opportunities for Clinical Trial Materials

5 Healthcare Cold Chain Logistic Services Market

• 5.1 Current and Historical Market Trends
• 5.2 Impact of COVID-19
• 5.3 Market Breakup by Product
  • 5.3.1 Clinical Trial Materials
  • 5.3.2 Vaccines
  • 5.3.3 Biopharmaceuticals
• 5.4 Market Breakup by Segment
  • 5.4.1 Transportation
    • 5.4.1.1 Current and Historical Market Trends
    • 5.4.1.2 Market Breakup by Transportation Type
    • 5.4.1.3 Market Forecast
  • 5.4.2 Packaging
    • 5.4.2.1 Current and Historical Market Trends
    • 5.4.2.2 Market Breakup by Packaging Type
    • 5.4.2.3 Market Forecast
  • 5.4.3 Instrumentation
    • 5.4.3.1 Current and Historical Market Trends
    • 5.4.3.2 Market Breakup by Instrumentation Type
    • 5.4.3.3 Market Forecast
• 5.5 Market by Region
  • 5.5.1 North America
  • 5.5.2 Europe
  • 5.5.3 Asia Pacific
  • 5.5.4 Rest of the World

6 Value Chain Analysis

• 6.1 Drug Production Facility
• 6.2 Refrigerated Warehouse
• 6.3 Transport (Air/Sea/Road/Rail)
• 6.4 Distribution centres
• 6.5 Transport (Road)
• 6.6 End Users

7 Price Analysis

• 7.1 Price Indicators
• 7.2 Price Structure
• 7.3 Cost of Cold Chain Logistic Services Vs. Non-Cold Chain Logistic Services

8 SWOT Analysis

• 8.1 Overview
• 8.2 Strengths
• 8.3 Weaknesses
• 8.4 Opportunities
• 8.5 Threats

9 Porter's Five Forces Analysis

• 9.1 Overview
• 9.2 Bargaining Power of Buyers
• 9.3 Bargaining Power of Suppliers
• 9.4 Degree of Competition
• 9.5 Threat of New Entrants
• 9.6 Threat of Substitutes

10 Healthcare Cold Chain Logistics: How Does It Operate?

• 10.1 Cold Chain Packaging and Transportation Methods
  • 10.1.1 Dry Ice
  • 10.1.2 Liquid Nitrogen
  • 10.1.3 Gel Packs
• 10.2 Setting Up a Cold Chain
  • 10.2.1 Initial Considerations
  • 10.2.2 Choosing the Correct Model
  • 10.2.3 Regulatory/Custom Clearance
  • 10.2.4 Final Stages
  • 10.2.5 Quality Assurance

11 Competitive Landscape

• 11.1 Market Structure
• 11.2 Key Players
• 11.3 Profiles of Key Players
  • 11.3.1 Amerisource Bergen Corporation (World Courier)
  • 11.3.2 Deutsche Post DHL Group
  • 11.3.3 FedEx Corporation Services, Inc.
  • 11.3.4 United Parcel Service of America, Inc.
  • 11.3.5 Kuehne + Nagel International AG, Cavalier Logistics, Inc.
  • 11.3.6 DB Schenker
  • 11.3.7 Life ConEx
  • 11.3.8 American Airlines Cargo
  • 11.3.9 Continental Group
  • 11.3.10 Marken